An editorial by Eddie Pauline, President and CEO
Soon, scientists for the MetroHealth System will develop and manufacture new gene therapy treatments to fight cancer and other diseases. They’ll do it in a new, state-of-the-art viral vector facility now under construction — just the latest development at the Cleveland Innovation District, a nearly $600 million investment by the state of Ohio, JobsOhio, and Cleveland’s five major medical and academic institutions.